Amicus Therapeutics
FOLD
#3313
Rank
โ‚น426.07 B
Marketcap
โ‚น1,357
Share price
0.07%
Change (1 day)
129.67%
Change (1 year)

Earnings for Amicus Therapeutics (FOLD)

Earnings in 2025 (TTM): โ‚น0.14 Billion

According to Amicus Therapeutics 's latest financial reports the company's current earnings are โ‚น0.63 Billion. , an increase over its 2024 earnings that were of -โ‚น2.7 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Amicus Therapeutics from 2007 to 2025

Annual earnings

Year Earnings Change
2025 โ‚น17.91 M-100.66%
2024 -โ‚น2.7 Billion-80.84%
2023 -โ‚น14.08 Billion-37.98%
2022 -โ‚น22.7 Billion0.2%
2021 -โ‚น22.66 Billion-11.92%
2020 -โ‚น25.72 Billion-22.94%
2019 -โ‚น33.38 Billion1.95%
2018 -โ‚น32.74 Billion-22.27%
2017 -โ‚น42.12 Billion120.39%
2016 -โ‚น19.11 Billion54.24%
2015 -โ‚น12.39 Billion88.63%
2014 -โ‚น6.57 Billion10.92%
2013 -โ‚น5.93 Billion21.36%
2012 -โ‚น4.88 Billion8.3%
2011 -โ‚น4.51 Billion-14.33%
2010 -โ‚น5.26 Billion753.76%
2009 -โ‚น0.62 Billion-83.31%
2008 -โ‚น3.7 Billion-4.4%
2007 -โ‚น3.87 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novo Nordisk
NVO
โ‚น1.965 T 10,974,559.69%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Biogen
BIIB
โ‚น145.96 B 814,821.47%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น927.97 B 5,180,931.41%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lexicon Pharmaceuticals
LXRX
-โ‚น6.44 Billion-36,004.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚น2.58 Billion-14,467.02%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น45.24 B 252,507.33%๐Ÿ‡บ๐Ÿ‡ธ USA